Acrivon Therapeutics
ACRV
#8361
Rank
A$0.29 B
Marketcap
$9.32
Share price
4.14%
Change (1 day)
41.05%
Change (1 year)

Acrivon Therapeutics (ACRV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : A$28.69 Million

According to Acrivon Therapeutics's latest financial reports the company's total liabilities are A$28.69 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Acrivon Therapeutics - Total liabilities on balance sheet (from 2021 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31A$15.79 M-91.22%
2021-12-31A$0.17 B1204.97%
2020-12-31A$13.78 M